Clinical research can be a meaningful new revenue stream for an independent specialty practice. It can also lose money if it is run poorly. Here is how research revenue actually works, what drives it, and what to watch for.

Where the money comes from

In an industry-sponsored trial, the sponsor pays the site to conduct the study. Payments are set in the study budget and clinical trial agreement, and usually include:

• Startup fees: one-time payments for site activation, regulatory work, and IRB preparation.

• Per-patient visit payments: paid for each completed protocol visit, and usually the largest share of revenue.

• Procedure fees: for protocol-required procedures, imaging, or tests.

• Screen failure payments: for patients who are screened but don't qualify, often capped.

• Pass-through and administrative fees: such as IRB fees, storage, or closeout.

How payments flow

Most sponsors pay in arrears, after visits are completed and data is entered, often monthly or quarterly. That means accurate visit tracking and invoicing are essential. Unbilled visits are lost revenue.

What drives revenue

• Enrollment: revenue follows patients. A study that enrolls well can be profitable; one that enrolls nobody usually costs money.

• Budget negotiation: the first budget offer is rarely the best one. Experienced negotiators know which costs to push on.

• Study mix: procedure-heavy studies often carry higher per-patient budgets.

• Efficiency: well-run visits, fewer data queries, and fewer protocol deviations protect margin.

What it costs to run

The main cost is people, especially clinical research coordinators. There are also regulatory, training, equipment, and software costs. For a practice building research on its own, those costs arrive before the revenue does. In a partnership model, the research partner typically covers setup and staffing, and study revenue is shared under a written agreement.

Compliance basics

Research payments come with rules. Compensation to physicians and practices should reflect fair market value for work actually performed, and financial arrangements should be reviewed by a healthcare attorney. Billing also needs care: some services in a trial are paid by the sponsor, while qualifying routine costs may be billed to insurance under rules such as Medicare's clinical trial policy. Billing the same service twice is a serious problem, so every study needs a clear billing plan.

Common pitfalls

• Accepting the sponsor's first budget without negotiation.

• Taking on studies that don't match the practice's patients.

• Missing invoiceable items like screen failures or unscheduled visits.

• Understaffing, which slows enrollment and increases errors.

• No clear billing plan for sponsor-paid versus insurance-billed services.

Beyond revenue

Revenue matters, but it is rarely the only reason practices add research. Patients gain access to new treatment options close to home, physicians contribute to their field, and the practice stands out in its market.

Whizz Health invests in setup and staffing, negotiates budgets, and tracks every study payment, with no upfront cost to the practice. See if your practice qualifies.